Thais Sielecki

Thais Sielecki is the COO at PolyCore Therapeutics LLC. Dr. Sielecki previously worked as Vice President, Preclinical Development of Cytokine PharmaSciences, Inc. At CPSI Dr. Sielecki ran programs from early lead discovery through to Phase 1 and assisted in Phase II and III study design as her primary focus. As part of the management team, she was also a member of teams to manage product portfolio, in-licensing, intellectual property management, and company strategy. Her experience spans oncology, inflammation, women’s health, CNS diseases, and antibacterials with a strong background in drug delivery and controlled release delivery systems. Dr. Sielecki has a PhD In medicinal chemistry from Colorado State University and completed a Post Doctoral research position at Stanford University. She has over 60 publications and patents over her career.